MedTech Dive October 17, 2025
Nalu’s implantable neurostimulation system delivers electrical impulses to treat chronic pain originating from the peripheral nerves.
Dive Brief:
- Boston Scientific said Friday it agreed to buy Nalu Medical, maker of a treatment for chronic peripheral nerve pain, to expand its neuromodulation portfolio.
- The company, which has been an investor in Nalu since 2017, said it will pay $533 million for the remaining equity that it does not already own. The purchase values Nalu at $600 million in total.
- Analysts said the transaction continues Boston Scientific’s strategy of expansion through tuck-in deals. “The acquisition fits Boston Scientific’s strategy of bringing in private investments to expand the portfolio,” Citi Research analyst Joanne Wuensch said in a note Friday.
Dive Insight:
...Today's Sponsors
Today's Sponsor